Skip to content
healthcare.dev

BLIP

NDC 82966-303, Nicotine Polacrilex, lozenge, from Blip Products, Inc..

Product NDC
82966-303
Status
Listed
Labeler
Blip Products, Inc.
Dosage form
LOZENGE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA203690
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82966-303 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NICOTINE4 mg/1

Pharmacologic classes

Cholinergic Nicotinic Agonist [EPC]; Nicotine [CS]

Package NDCNDC-11Package
82966-303-00829660303001 CONTAINER in 1 CARTON (82966-303-00) / 27 LOZENGE in 1 CONTAINER (82966-303-27)
82966-303-10829660303104 CONTAINER in 1 CARTON (82966-303-10) / 27 LOZENGE in 1 CONTAINER (82966-303-27)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 82966-303 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82966-303 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82966-303. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.